Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderich E Schwarz

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infectionAdam C Yopp, Madhu Subramanian, Mamta K Jain, et al.
Journal of Cellular and Molecular Medicine|May 3, 2021
Targeted dual inhibition of c-Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer modelsMeghan Grojean, Margaret A Schwarz, Johann R Schwarz, et al.
Annals of Surgical Oncology|September 6, 2014
Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-upLeonard R Henry, Richard B Hostetter, Brittany Ressler, et al.
American Journal of Clinical Oncology|February 11, 2003
Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysisRoderich E Schwarz, David D Smith, Hemant Keny, et al.
Surgery|August 27, 2013
Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?Christina L Roland, Roderich E Schwarz, Liyue Tong, et al.
Journal of Surgical Oncology|October 19, 2011
Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypesChristina L Roland, Aihua Bian, John C Mansour, et al.
American Journal of Surgery|November 22, 2017
Quality measurement affecting surgical practice: Utility versus utopiaLeonard R Henry, Urs W von Holzen, Michael J Minarich, et al.
Nature Reviews. Urology|February 10, 2011
Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCCToshinari Yamasaki, Tram Anh T Tran, Orhan K Oz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2012
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancerAmanda Kirane, Jason E Toombs, Katherine Ostapoff, et al.
Biochemical Pharmacology|September 18, 2018
Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motilityNorbert Kuc, Allison Doermann, Carolyn Shirey, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infectionAdam C Yopp, Madhu Subramanian, Mamta K Jain, et al.
Journal of Cellular and Molecular Medicine|May 3, 2021
Targeted dual inhibition of c-Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer modelsMeghan Grojean, Margaret A Schwarz, Johann R Schwarz, et al.
Annals of Surgical Oncology|September 6, 2014
Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-upLeonard R Henry, Richard B Hostetter, Brittany Ressler, et al.
American Journal of Clinical Oncology|February 11, 2003
Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysisRoderich E Schwarz, David D Smith, Hemant Keny, et al.
Surgery|August 27, 2013
Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?Christina L Roland, Roderich E Schwarz, Liyue Tong, et al.
Journal of Surgical Oncology|October 19, 2011
Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypesChristina L Roland, Aihua Bian, John C Mansour, et al.
American Journal of Surgery|November 22, 2017
Quality measurement affecting surgical practice: Utility versus utopiaLeonard R Henry, Urs W von Holzen, Michael J Minarich, et al.
Nature Reviews. Urology|February 10, 2011
Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCCToshinari Yamasaki, Tram Anh T Tran, Orhan K Oz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2012
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancerAmanda Kirane, Jason E Toombs, Katherine Ostapoff, et al.
Biochemical Pharmacology|September 18, 2018
Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motilityNorbert Kuc, Allison Doermann, Carolyn Shirey, et al.
Pageof 11